Employing nanoparticle self-assembly concepts, SoluBest's scientists have developed a platform for improving the bio-performance of poorly soluble drugs. This robust technological platform, Solumer™, is versatile as it can be applied to a wide range of pharmaceuticals, and requires a relatively short time for screening potentially feasible candidates (a few weeks per project). Solumerization enables the design and production of new self-assembled drug-polymer complexeswith unique physico-chemical properties.